Rhumbline Advisers boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 9.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,405,296 shares of the real estate investment trust's stock after acquiring an additional 120,631 shares during the period. Rhumbline Advisers owned approximately 0.20% of Healthpeak Properties worth $28,415,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOC. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock valued at $493,115,000 after purchasing an additional 4,056,931 shares in the last quarter. E. Ohman J or Asset Management AB lifted its holdings in shares of Healthpeak Properties by 32.8% during the 4th quarter. E. Ohman J or Asset Management AB now owns 36,445 shares of the real estate investment trust's stock valued at $739,000 after purchasing an additional 9,000 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Healthpeak Properties by 16.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust's stock valued at $2,217,000 after buying an additional 15,753 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in Healthpeak Properties by 5.6% in the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 233,767 shares of the real estate investment trust's stock valued at $4,738,000 after buying an additional 12,358 shares in the last quarter. Finally, Lightrock Netherlands B.V. bought a new position in Healthpeak Properties in the fourth quarter valued at approximately $5,689,000. 93.57% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently commented on the stock. Wedbush cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Wells Fargo & Company cut their price target on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a report on Monday. Robert W. Baird cut their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. Evercore ISI cut their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Scotiabank cut their target price on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research note on Monday, May 12th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties currently has an average rating of "Moderate Buy" and a consensus price target of $23.27.
View Our Latest Report on DOC
Insider Activity
In other Healthpeak Properties news, Director Tommy G. Thompson purchased 5,700 shares of the company's stock in a transaction that occurred on Friday, May 9th. The shares were acquired at an average price of $17.36 per share, for a total transaction of $98,952.00. Following the purchase, the director now owns 138,513 shares in the company, valued at approximately $2,404,585.68. The trade was a 4.29% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director John T. Thomas purchased 4,200 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the purchase, the director now owns 813,566 shares in the company, valued at $14,514,017.44. This trade represents a 0.52% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 29,764 shares of company stock valued at $521,909. 0.23% of the stock is owned by company insiders.
Healthpeak Properties Trading Down 0.2%
Shares of Healthpeak Properties stock opened at $17.06 on Friday. Healthpeak Properties, Inc. has a 12-month low of $16.64 and a 12-month high of $23.26. The stock has a market cap of $11.85 billion, a P/E ratio of 48.76, a P/E/G ratio of 2.17 and a beta of 1.05. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The business's 50 day moving average is $17.92 and its 200-day moving average is $19.61.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. During the same period in the prior year, the firm posted $0.45 earnings per share. The company's quarterly revenue was up 15.9% compared to the same quarter last year. Equities research analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Dividend Announcement
The company also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's payout ratio is 305.00%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report